FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website
horizonal rule
Dockets Management

Back



1980N-0208
C 37
Volume 151

Comment

Department of Defense memorandum, October 27, 2000

Department of Defense memorandum, August 6, 2002

Hart MK, DelGiudice RA, Korch GW. Absence of Mycoplasma contamination in anthrax vaccine. Emerging Infectious Diseases 2002; 7: 94-96. http://www.cdc.gov/ncidod/eid/vol8no1/01-0091.htm Published Material

Hoffman K, Costello C, Menich M, Grabenstein JD, Engler RJM. Using a structured medical note for determining the safety profile of anthrax vaccine for U.S. Soldiers in Korea. Vaccine 2003; 21 (Oct 1): 4399-4409. www.anthrax.mil/documents/library/VaccineJournalVol%2021.pdf Published Material

Lange JL, Lesikar SE, Brundage JF, Rubertone MV. Comprehensive systematic surveillance for adverse effects of anthrax vaccine adsorbed, US Armed Forces, 1998-2000. Vaccine 2003; 21 (Apr 2): 1620-28. www.anthrax.mil/documents/library/science.pdf Published Material

Mahan CM, Kang HK, Dalager NA, Heller JM. Anthrax vaccination and self-reported symptoms, functional status, and medical conditions in the National Health Survey of Gulf War Era Veterans and Their Families. Annals of Epidemiology 2004; 14 (2): 81-8. http://www.annalsofepidemiology.org/article/PIIS1047279703001248/abstract Published Material

Pittman PR, Coonan KM, Gibbs PH, Scott HM, Cannon TL, McKee KT Jr. Long-term health effects of repeated exposure to multiple vaccines. Vaccine 2004; 23: 525-36. www.vaccines.mil/documents/library/Longtermhealtheffects.pdf Published Material

Sever JL, Brenner AI, Gale AD, Lyle JM, Moulton LH, West DJ. Safety of anthrax vaccine: A review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). Pharmacoepidemiology & Drug Safety 2004; 13: 825-840. http://www.anthrax.mil/media/pdf/SeverArticle.pdf Published Material

Sever JL, Brenner AI, Gale AD, Lyle JM, Moulton LH, West DJ. Safety of anthrax vaccine: A review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). Pharmacoepidemiology & Drug Safety 2002; 11: 189-202. http://www.anthrax.mil/media/pdf/AVEC_ms.pdf Published Material

Sulsky SI, Grabenstein JD, Delbos RG. Disability among U.S. Army personnel vaccinated against anthrax. Journal of Occupational & Environmental Medicine 2004; 46: 1065-1075. http://www.anthrax.mil/documents/library/Anthrax2004.pdf Published Material

United States Pharmacopeia, 27th Revision, First Supplement. Anthrax vaccine adsorbed. Rockville, MD: United States Pharmacopeial Convention, Inc., 2003 (Jul): 3042-3044. Published Material

Wasserman GM, Grabenstein JD, Pittman PR, Rubertone MV, Gibbs PP, Wang LZ, Golder LG. Analysis of adverse events after anthrax vaccination in US Army medical personnel. Journal of Occupational & Environmental Medicine 2003;45:222-33. www.anthrax.mil/documents/library/AnthraxVaccineEvaluation.pdf Published Material

White CS III, Adler WH, McGann VG. Repeated immunization: Possible adverse effects: Reevaluation of human subjects at 25 years. Ann Intern Med 1974; 81: 594-600. www.anthrax.mil/media/pdf/Repeated.pdf Published Material

Detailed Discussion of Squalene and Anti-Squalene Antibodies in Relation to Anthrax Vaccine. Content posted at www.anthrax.mil/squalene, 100 pages

Matyas, GR et al. Induction and detection of antibodies to squalene. Journal of Immunological Methods 245 (2000) 1-14. Published Material

Matyas, GR et al. Induction and detection of antibodies to squalene II. Optimization of the assay for murine antibodies. Journal of Immunological Methods 267 (2002) 119- 129. Published Material

Matyas, GR et al. Detection of antibodies to squalene III. Naturally occurring antibodies to squalene in humans and mice. Journal of Immunological Methods 286 (2004) 47-67. Published Material

Sever JL, Brenner AI, Gale AD, Lyle JM, Moulton LH, West DJ. Safety of anthrax vaccine: A review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). Pharmacoepidemiology & Drug Safety 2004; 13: 825-840. http://www.anthrax.mil/media/pdf/SeverArticle.pdf Published Material

Sever JL, Brenner AI, Gale AD, Lyle JM, Moulton LH, West DJ. Safety of anthrax vaccine: A review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). Pharmacoepidemiology & Drug Safety 2002; 11: 189-202. http://www.anthrax.mil/media/pdf/AVEC_ms.pdf Published Material


Top | Back

Page last updated July 27, 2005 RSChorizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management